0000000001109047

AUTHOR

M Petrini

showing 2 related works from this author

Implant insertion torque value in immediate loading : a retrospective study

2019

Background The aim of this study is to verify if the Insertion Torque Value (ITV) of 32 Ncm for immediate loading protocol (ILP), as indicated by literature, is still, with the advance in implant research, a real significant cut-off for long-term implant survival. Material and Methods In this retrospective study, data from 224 patients that during three years of clinical practice, were submitted to the insertion of 322 implants with immediate loading protocol, have been recorded, pooled and analyzed. Data were organized based on Insertion Torque Value (ITV): > 32 Ncm (CG) and 32 Ncm are still characterized by a lower crestal bone resorption, there are no statistically significant difference…

Insertion torqueImmediate Dental Implant LoadingDentistryBone resorption03 medical and health sciencesDental Implants Single-Tooth0302 clinical medicineHumansMedicineDental Restoration FailureGeneral DentistrySurvival rateRetrospective StudiesDental Implantsbusiness.industryResearchDental Implantation EndosseousImplant failureRetrospective cohort study030206 dentistryOdds ratio:CIENCIAS MÉDICAS [UNESCO]TorqueOtorhinolaryngologySample size determinationUNESCO::CIENCIAS MÉDICASSurgeryImplantOral Surgerybusiness
researchProduct

Repeated courses of granulocyte colony-stimulating factor in amyotrophic lateral sclerosis: clinical and biological results from a prospective multic…

2011

Granulocyte colony-stimulating factor (G-CSF) induces a transient mobilization of hematopoietic progenitor cells from bone marrow to peripheral blood. Our aim was to evaluate safety of repeated courses of G-CSF in patients with amyotrophic lateral sclerosis (ALS), assessing disease progression and changes in chemokine and cytokine levels in serum and cerebrospinal fluid (CSF). Twenty-four ALS patients entered an open-label, multicenter trial in which four courses of G-CSF and mannitol were administered at 3-month intervals. Levels of G-CSF were increased after treatment in the serum and CSF. Few and transitory adverse events were observed. No significant reduction of the mean monthly decrea…

Keywords:amyotrophic lateral sclerosiclinical trialhematopoietic stem cellSettore MED/26 - Neurologiagranulocyte colony-stimulating factorneuroinflammation
researchProduct